1. What observational datasets are the authors going to use to “validate” these findings.
2. Why start with so many clinical conditions, why not use 1 as a “test case” like SGLT-2 inhibition.
Need further explanation as above.
1. What observational datasets are the authors going to use to “validate” these findings.
2. Why start with so many clinical conditions, why not use 1 as a “test case” like SGLT-2 inhibition.
Need further explanation as above.